United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

orexigen therapeutics ireland ltd - bupropion hydrochloride; naltrexone hydrochloride - modified-release tablet - 90mg ; 8mg

United States - English - NLM (National Library of Medicine)

sandoz inc - methazolamide (unii: w733b0s9sd) (methazolamide - unii:w733b0s9sd) - methazolamide 25 mg - methazolamide is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery. methazolamide therapy is contraindicated in situations in which sodium and/or potassium serum levels are depressed, in cases of marked kidney or liver disease or dysfunction, in adrenal gland failure, and in hyperchloremic acidosis. in patients with cirrhosis, use may precipitate the development of hepatic encephalopathy. long-term administration of methazolamide is contraindicated in patients with angle-closure glaucoma, since organic closure of the angle may occur in spite of lowered intraocular pressure.

European Union - English - EMA (European Medicines Agency)

orexigen therapeutics ireland limited - bupropion hydrochloride, naltrexone hydrochloride - obesity; overweight - antiobesity preparations, excl. diet products - mysimba is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (≥18 years) with an initial body mass index (bmi) of≥ 30 kg/m2 (obese), or≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co morbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension)treatment with mysimba should be discontinued after 16 weeks if patients have not lost at least 5% of their initial body weight.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

orexigen therapeutics ireland limited, ireland - bupropion hcl , naltrexone hcl - prolonged-release tablet - 90 , 8 mg

European Union - English - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - obesity - antiobesity preparations, excl. diet products - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

algorithm sal, lebanon - bupropion hydrochloride,naltrexone hydrochloride - prolonged-release tablet - 90,8 mg,

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety

Israel - English - Ministry of Health

cts chemical industries ltd, israel - phentermine as resinate - capsules - phentermine as resinate 15 mg - phentermine - phentermine - for the treatment of severe obesity that has not responded to an appropriate diet - a minimal body mass index of 30 kg/m2 is required.

Singapore - English - HSA (Health Sciences Authority)

eurodrug laboratories singapore pte. ltd. - phentermine hcl - capsule - 15 mg - phentermine hcl 15 mg

Singapore - English - HSA (Health Sciences Authority)

eurodrug laboratories singapore pte. ltd. - phentermine hcl - capsule - 30 mg - phentermine hcl 30 mg